Cargando…

Validation of a vision-related activity scale for patients with retinitis pigmentosa

PURPOSE: There have been few systematic reports of vision-related activity limitations of people with retinitis pigmentosa (RP). We report a merging of data from the National Eye Institute Visual Function Questionnaire (NEI-VFQ) obtained in five previous studies. We asked whether the Vision Function...

Descripción completa

Detalles Bibliográficos
Autores principales: Costela, Francisco M., Pesudovs, Konrad, Sandberg, Michael A., Weigel-DiFranco, Carol, Woods, Russell L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310073/
https://www.ncbi.nlm.nih.gov/pubmed/32571342
http://dx.doi.org/10.1186/s12955-020-01427-8
_version_ 1783549299643121664
author Costela, Francisco M.
Pesudovs, Konrad
Sandberg, Michael A.
Weigel-DiFranco, Carol
Woods, Russell L.
author_facet Costela, Francisco M.
Pesudovs, Konrad
Sandberg, Michael A.
Weigel-DiFranco, Carol
Woods, Russell L.
author_sort Costela, Francisco M.
collection PubMed
description PURPOSE: There have been few systematic reports of vision-related activity limitations of people with retinitis pigmentosa (RP). We report a merging of data from the National Eye Institute Visual Function Questionnaire (NEI-VFQ) obtained in five previous studies. We asked whether the Vision Function Scale (VFS; Pesudovs et al., 2010) which was developed for cataract patients would apply in this new population (condition). METHODS: Five hundred ninety-four individuals completed a total of 1753 questionnaires, with 209 participants providing responses over at least 4 years. Rasch analysis showed that the 15-item VFS was poorly targeted. A new instrument created by adding four driving-related items to the VFS had better targeting. As an indirect validation, VFS-plus person scores were compared to visual field area measured using a Goldmann perimeter, to the summed score for the combined 30–2 and 30/60–1 Humphrey Field Analyzer programs (HFA), to 30-Hz full-field cone electroretinogram (ERG) amplitude, and to ETDRS visual acuity. Changes in VFS-plus person scores with age and between four common heredity groups were also examined. RESULTS: The Rasch model of responses to the 19 VFS-plus items had person and item separation of 2.66 and 24.43 respectively. The VFS-plus person scores were related to each vision measure (p < 0.001). Over a five-year period, there was a reduction in person scores of 0.5 logits (p < 0.001). Person scores fell by an average of 0.34 logits per decade (p < 0.0001). Participants with an X-linked hereditary pattern had, on average, lower person scores (p < 0.001). CONCLUSIONS: The VFS-plus instrument quantified a highly-significant annual reduction in perceived vision-related ability over a five-year period. The outcome was consistent with clinical measures of vision, and detected lower perceived vision-related ability in participants with X-linked disease. It may be of use in future studies, but this needs to be tested in a representative population sample.
format Online
Article
Text
id pubmed-7310073
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73100732020-06-23 Validation of a vision-related activity scale for patients with retinitis pigmentosa Costela, Francisco M. Pesudovs, Konrad Sandberg, Michael A. Weigel-DiFranco, Carol Woods, Russell L. Health Qual Life Outcomes Research PURPOSE: There have been few systematic reports of vision-related activity limitations of people with retinitis pigmentosa (RP). We report a merging of data from the National Eye Institute Visual Function Questionnaire (NEI-VFQ) obtained in five previous studies. We asked whether the Vision Function Scale (VFS; Pesudovs et al., 2010) which was developed for cataract patients would apply in this new population (condition). METHODS: Five hundred ninety-four individuals completed a total of 1753 questionnaires, with 209 participants providing responses over at least 4 years. Rasch analysis showed that the 15-item VFS was poorly targeted. A new instrument created by adding four driving-related items to the VFS had better targeting. As an indirect validation, VFS-plus person scores were compared to visual field area measured using a Goldmann perimeter, to the summed score for the combined 30–2 and 30/60–1 Humphrey Field Analyzer programs (HFA), to 30-Hz full-field cone electroretinogram (ERG) amplitude, and to ETDRS visual acuity. Changes in VFS-plus person scores with age and between four common heredity groups were also examined. RESULTS: The Rasch model of responses to the 19 VFS-plus items had person and item separation of 2.66 and 24.43 respectively. The VFS-plus person scores were related to each vision measure (p < 0.001). Over a five-year period, there was a reduction in person scores of 0.5 logits (p < 0.001). Person scores fell by an average of 0.34 logits per decade (p < 0.0001). Participants with an X-linked hereditary pattern had, on average, lower person scores (p < 0.001). CONCLUSIONS: The VFS-plus instrument quantified a highly-significant annual reduction in perceived vision-related ability over a five-year period. The outcome was consistent with clinical measures of vision, and detected lower perceived vision-related ability in participants with X-linked disease. It may be of use in future studies, but this needs to be tested in a representative population sample. BioMed Central 2020-06-22 /pmc/articles/PMC7310073/ /pubmed/32571342 http://dx.doi.org/10.1186/s12955-020-01427-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Costela, Francisco M.
Pesudovs, Konrad
Sandberg, Michael A.
Weigel-DiFranco, Carol
Woods, Russell L.
Validation of a vision-related activity scale for patients with retinitis pigmentosa
title Validation of a vision-related activity scale for patients with retinitis pigmentosa
title_full Validation of a vision-related activity scale for patients with retinitis pigmentosa
title_fullStr Validation of a vision-related activity scale for patients with retinitis pigmentosa
title_full_unstemmed Validation of a vision-related activity scale for patients with retinitis pigmentosa
title_short Validation of a vision-related activity scale for patients with retinitis pigmentosa
title_sort validation of a vision-related activity scale for patients with retinitis pigmentosa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310073/
https://www.ncbi.nlm.nih.gov/pubmed/32571342
http://dx.doi.org/10.1186/s12955-020-01427-8
work_keys_str_mv AT costelafranciscom validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa
AT pesudovskonrad validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa
AT sandbergmichaela validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa
AT weigeldifrancocarol validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa
AT woodsrusselll validationofavisionrelatedactivityscaleforpatientswithretinitispigmentosa